|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Tumor infiltrating lymphocytes in triple negative breast cancer receiving neoadjuvant chemotherapy显示文摘AIM To determine influence of neoadjuvant-chemotherapy(NAC) over tumor-infiltrating-lymphocytes(TIL) intriple-negative-breast-cancer(TNBC).METHODS TILs were evaluated in 98 TNBC cases who came to Instituto Nacional de Enfermedades Neoplasicas from 2005 to 2010. Immunohistochemistry staining for CD3, CD4, CD8 and FOXP3 was performed in tissue microarrays(TMA) sections. Evaluation of H/E in full-face and immunohistochemistry in TMA sections was performed in pre and post-NAC samples. STATA software was used and P value < 0.05 was considered statistically significant. RESULTS Higher TIL evaluated in full-face sections from pre-NAC tumors was associated to pathologic-complete-response(pCR)(P = 0.0251) and outcome(P = 0.0334). TIL evaluated in TMA sections showed low level of agreement with full-face sections(ICC = 0.017-0.20) and was not associated to pCR or outcome. TIL in post-NAC samples were not associated to response or outcome. PostNAC lesions with pC R had similar TIL levels than those without pCR(P = 0.6331). NAC produced a TIL decrease in full-face sections(P < 0.0001). Percentage of TIL subpopulations was correlated with their absolute counts. Higher counts of CD3, CD4, CD8 and FOXP3 in pre-NAC samples had longer disease-free-survival(DFS). Higher counts of CD3 in pre-NAC samples had longer overallsurvival. Higher ratio of CD8/CD4 counts in pre-NAC was associated with pCR. Higher ratio of CD4/FOXP3 counts in pre-NAC was associated with longer DFS. Higher counts of CD4 in post-NAC samples were associated with pCR.CONCLUSION TIL in pre-NAC full-face sections in TNBC are correlated to longer survival. TIL in full-face differ from TMA sections, absolute count and percentage analysis of TIL subpopulation closely related. | Carlos A Castaneda Elizabeth Mittendorf Sandro Casavilca Yun Wu Miluska Castillo Patricia Arboleda Teresa Nunez Henry Guerra Carlos Barrionuevo Ketty Dolores-Cerna Carolina Belmar-Lopez Julio Abugattas Gabriela Calderon Miguel De La Cruz Manuel Cotrina Jorge Dunstan Henry L Gomez Tatiana Vidaurre | 2016 | World Journal of Clinical Oncology2016,7,5: | 6 |
| 2 | Clinicopathological predictors of long-term benefit in breast cancer treated with neoadjuvant chemotherapy显示文摘AIM To investigate the survival impact of clinicopathological factors, including pathological complete response(p CR) and tumor-infiltrating lymphocytes(s TIL) levels according to subtypes, in breast cancer(BC) patients who received neo-adjuvant chemotherapy(NAC).METHODS We evaluated 435 BC patients who presented and received NAC at the Instituto Nacional de Enfermedades Neoplasicas from 2003 to 2014. s TIL was analyzed as the proportion of tumor stroma occupied by lymphocytes, and was prospectively evaluated on hematoxylin and eosin-stained sections of the preN AC core biopsy. p CR was considered in the absence of infiltrating cancer cells in primary tumor and axillary lymph nodes. Analysis of statistical association between clinical pathological features, s TIL, p CR and survival were carried out using SPSSvs19.RESULTS Median age was 49 years(range 24-84 years) and the most frequent clinical stage was ⅢB(58.3%). Luminal A, Luminal B, HER2-enriched and(triple-negative) TN phenotype was found in 24.6%, 37.9%, 17.7% and 19.8%, respectively. p CR was observed in 11% and median percentage of s TIL was 40%(2%-95%) in the whole population. p CR was associated to Ct1-2(P = 0.045) and to high s TIL(P = 0.029) in the whole population. There was a slight trend towards significance for s TIL(P = 0.054) in Luminal A. s TIL was associated with grade Ⅲ(P < 0.001), no-Luminal A subtype(P < 0.001), RE-negative(P < 0.001), PgR-negative(P < 0.001), HER2-positive(P = 0.002) and p CR(P = 0.029) in the whole population. Longer disease-free survival was associated with grade Ⅰ-Ⅱ(P = 0.006), cN 0(P < 0.001), clinical stage Ⅱ(P = 0.004), ER-positive(P < 0.001), Pg R-positive(P < 0.001), luminal A(P < 0.001) and p CR(P = 0.002). Longer disease-free survival was associated with grade Ⅰ-Ⅱ in Luminal A(P < 0.001), N0-1 in Luminal A(P = 0.045) and TNBC(P = 0.01), clinical stage Ⅱ in Luminal A(P = 0.003) and TNBC(P = 0.038), and pC R in TNBC(P < 0.001). Longer overall survival was associated with grade Ⅰ-Ⅱ(P < 0.001), ER-positive(P < 0.001), PgR-positive(P < 0.001), Luminal A(P < 0.001), cN 0(P = 0.002) and p CR(P = 0.002) in the whole population. Overall survival was associated with clinical stage Ⅱ(P = 0.017) in Luminal A, older age(P = 0.042) in Luminal B, and pC R in TNBC(P = 0.005).CONCLUSION Predictive and prognostic values of clinicopathological features, like p CR and s TIL, differ depending on the evaluated molecular subtype. | Marco Galvez Carlos A Castaneda Joselyn Sanchez Miluska Castillo Lia Pamela Rebaza Gabriela Calderon Miguel De La Cruz Jose Manuel Cotrina Julio Abugattas Jorge Dunstan Henry Guerra Omar Mejia Henry L Gomez | 2018 | World Journal of Clinical Oncology2018,9,2: | 4 |
| 3 | Enzymatic hydrolysis and synthesis of soy protoin to improve its amino acid composition and functional properties显示文摘 | CALDERON DE LA BARCA A M RUIZ-SALAZAR R A JARA- MARINI M E | 2000 | Food Chemistry and Toxicology2000,65,2: | 1 |
| 4 | The costs and benefits of combining different IP mobility standards 显示文摘 | DE LA OLIVA A SOTO I CALDERON M | 2013 | Computer Standards & Interfaces2013,35,2: | 1 |
| 5 | Pneumocystis jiroveci jislates with dihydropteroate synthase mutations in patients with chronic bronchitis显示文摘 | Calderon E de la Horra C medrano FJ | 2004 | ClinMicrobiol Infect Dis2004,23,7: | 1 |
| 6 | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties 显示文摘 | Calderon de la Barca A M Ruiz Salazar R A Jara Marini M E | 2000 | Food Chemistry and Toxicology2000,65,2: | 1 |
| 7 | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties 显示文摘 | Calderon - de - la B A M Ruiz - Salazar | 2000 | Food Science2000,65,2: | 1 |
| 8 | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties 显示文摘 | Calderon de la Barca A M Ruiz-Salazar R A Jara-Marini M E | 2000 | Food Chemistry and Toxicology2000,65,2: | 1 |
| 9 | Molecular characterization of canine parvovirus strains in Argentina: Detection of the pathogenic variant CPV2c in vaccinated dogs显示文摘 | Marina Gallo Calderon Nora Mattion Danilo Bucafusco Fernando Fogel Patricia Remorini Jose La Torre | 2009 | Journal of Virological Methods2009,,2: | 1 |
| 10 | Endoscopic submucosal dissection显示文摘 | Fernandez-Esparrach G Calderon A De La Pena J | 2014 | Endoscopy2014,46,: | 1 |
| 11 | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties显示文摘 | Calderon de la Barca A M Ruiz-Salazar R A Jara-Marini M E | 2000 | Journal of Food Science2000,65,2: | 1 |
| 12 | Analysis of recombinant monoclonal anti- bodies by capillary zone electrophoresis 显示文摘 | Espinosa-de la Garza CE Perdomo-Abtandez FC Padilla- Calderon J | 2013 | Electrophoresis2013,34,8: | 1 |
| 13 | Association of population and primary healthcare factors with hospital admission rates for chronic obstructive pulmonary disease in England:National cross- sectional study显示文摘 | Calderon LA Carney L Soliak M | 2011 | Thorax2011,66,3: | 1 |
| 14 | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties显示文摘 | A M Calderon de la Barca R A Ruiz-Salazar M E Jara-Marini | 2000 | Food chemistry and toxicology2000,65,2: | 1 |
| 15 | Enzymatic hydrolysis and synthesis of soy protein to improve its amino acid composition and functional properties 显示文摘 | Calderon de la Barca A M Ruiz-Salazar R A Jara-Marini M E | 2000 | J Food Sci2000,65,2: | 1 |